Discover the secrets of biology and human health with a proteogenomic approach

Join us at ESHG (European Human Genetics Conference)

Messe Berlin, CityCube, Germany  |  June 1 – 4, 2024

Join our sponsored session (details below) and stop by Booth 546 to learn more about the most powerful proteomics solution today – covering half of the genetically encoded human proteome. Researchers can now decipher human biology by casting the widest net possible with the SomaScan 11K Assay.

Icon depicting tradeshow booth

Stop by
Booth 546

Come by our booth to speak to our team and share more about your genetics research.

Icon depicting group watching a presentation

Attend our
sponsored presentations

Put our speaker session on your calendar to learn more about integrating proteomics and genomics data. Details below.


From Discovery to Clinical Insights – the power of integrating proteomics and genomics data

Saturday, 1 June | 10:00-11:30 a.m. | Location: New York 2

The power of high-plex proteomics: from biomarker discovery to clinical diagnosis

Tala Khosroheidari, PhD

Tala Khosroheidari, Senior Director of Global Scientific Engagement, SomaLogic
Proteogenomic approaches to inform drug target discovery and repurposing

Maik Pietzner, PhD

Maik Pietzner, PhD, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
Recent advancements in the field of proteomics have revolutionized the field of multiomics. The SomaScan® Assay from SomaLogic is the only proteomic technology capable of high-plex (measuring over half of the human proteome – 11,000 proteins), high-throughput (rapid processing time and data turnaround), and high sensitivity (measuring both high- and low-abundant proteins) from a single biological sample. Please join us to learn the value of adding high-plex proteomics to existing genomics data and how proteogenomic approaches accelerate drug target discovery and repurposing.

Why a proteogenomic appraoch?